Artwork

Content provided by Siegel Rare Neuroimmune Association (SRNA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Siegel Rare Neuroimmune Association (SRNA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

1106. CosMOG - Clinical Trial for MOGAD Treatment

20:39
 
Distribuie
 

Manage episode 361526611 series 2146736
Content provided by Siegel Rare Neuroimmune Association (SRNA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Siegel Rare Neuroimmune Association (SRNA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

For this episode of “Ask the Expert: Research Edition,” Krissy Dilger of SRNA was joined by Dr. Michael Levy. Dr. Levy gave an explanation of MOG antibody disease (MOGAD) and an overview of CosMOG, an ongoing clinical trial of rozanolixizumab for MOGAD treatment. He shared details about safety issues, the design of the trial, inclusion criteria, and where someone could learn more about the trial and participation.

  continue reading

146 episoade

Artwork
iconDistribuie
 
Manage episode 361526611 series 2146736
Content provided by Siegel Rare Neuroimmune Association (SRNA). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Siegel Rare Neuroimmune Association (SRNA) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

For this episode of “Ask the Expert: Research Edition,” Krissy Dilger of SRNA was joined by Dr. Michael Levy. Dr. Levy gave an explanation of MOG antibody disease (MOGAD) and an overview of CosMOG, an ongoing clinical trial of rozanolixizumab for MOGAD treatment. He shared details about safety issues, the design of the trial, inclusion criteria, and where someone could learn more about the trial and participation.

  continue reading

146 episoade

모든 에피소드

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință